Latest AbbVie News & Updates
See the latest news and media coverage for AbbVie. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical company
abbvie.com- Headquarters
- North Chicago, United States
- Company type
- Public company
- Number of employees
- 60,000+
Last updated
Latest news about AbbVie
In short: AbbVie exceeded Q1 2026 revenue expectations with $15 billion, raised its full-year outlook, and announced a $1.4 billion manufacturing investment.
Company announcements
-
AbbVie reports first-quarter 2026 financial results
Net revenues reach $15.002 billion, up 12.4%. Raises full-year adjusted EPS guidance to $14.08-$14.28. Key portfolios show strong growth in immunology and neuroscience.
-
AbbVie submits FDA application for RINVOQ in severe alopecia areata
Submission supported by Phase 3 UP-AA trials showing substantial scalp hair regrowth at week 24 and beyond.
-
AbbVie submits FDA application for SKYRIZI subcutaneous induction
The submission is supported by Phase 3 AFFIRM study data for adults with moderately to severely active Crohn's disease. Approval would offer SC induction option alongside IV.
-
AbbVie receives FDA CRL for TrenibotE BLA
The FDA requests manufacturing information without safety or efficacy issues or new studies. AbbVie plans a prompt response. Reviews continue elsewhere.
Media coverage
-
AbbVie Delivers Strong Q1 Earnings Beyond Humira. This Dividend King Still Shines.
Abbvie Inc logo and meds- by Ascannio via Shutterstock AbbVie (ABBV) has built a solid reputation...
-
AbbVie Highlights New Long-Term Data Advancing Treatment Standards in...
AbbVie will present 18 abstracts, including real-world evidence and long-term findings for SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) in Crohn's disease and ulcerative colitis.
-
Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus
The 185-acre site will be the company's largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.
-
US FDA declines to approve AbbVie's wrinkle treatment due to manufacturing concerns (April 23)
(Corrects headline to say the FDA "declines" to approve the treatment and not "rejects". Also corrects first bullet to say the treatment starts to work...
Track AbbVie and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
AbbVie competitors & trending companies
Browse news for competitors to AbbVie and other trending companies.
AstraZeneca
Lilly
Biogen
Novartis
MSD
BMS
Sanofi
GSK
Amgen
UCB
Gilead
J&J
Roche
Merck
Pfizer
Regeneron
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy